medicalmarketnews.com
Blueprint Wins FDA Approval for $32,000 Stomach Cancer Treatment - Medical Market News
The U.S. Food and Drug Administration (FDA) permitted Blueprint Medicines Corp’s oral therapy to deal with a rare type of cancer that impacts the stomach and small gut, the agency stated on Thursday. The FDA’s choice makes the remedy, Ayvakit, the first remedy for a small subset of sufferers with a mutation of the most …